Perspective Therapeutics Inc (CATX)

3.165 +0.32 (+11.05%) USD  |  NYAM  |  Dec 23, 16:00
3.165 0.00 (0.00%) After-Hours: 19:20
More

Perspective Therapeutics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for CATX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Plus Therapeutics Inc --
Retractable Technologies Inc Upgrade
InfuSystems Holdings Inc --
Xtant Medical Holdings Inc Upgrade
Catheter Precision Inc Upgrade